Innovative active virosomes to tackle unmet medical needs in infectious disease and oncology

Based on a highly-modified measles virus, active virosomes can express foreign genes and proteins on the surface and transfer mRNA for expression in the target cells upon infection.

The platform has been designed to be extremely flexible. Thanks to its validated cassette system, new vaccines and therapies can be generated within a few weeks using existing measles processes.